Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23

Clinical Cancer Research

Volumn 2, Issue 6, 1996, Pages 1039-1048

  Ellis, William J ^a   Vessella, Robert L ^b   Buhler, Kent R ^b   Bladou, Franck ^b   True, Lawrence D ^b   Bigler, Steven A ^b   Curtis, Dena ^b   Lange, Paul H ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN;

ADULT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER TRANSPLANTATION; CASE REPORT; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CARCINOMA; XENOGRAFT;

ACID PHOSPHATASE; ANIMALS; CHROMOSOME ABERRATIONS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; NEOPLASM TRANSPLANTATION; ORCHIECTOMY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0029938570     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Boring, C. C., Squires, T. S., and Tong, T. Cancer statistics, 1993. CA Cancer J. Clin., 43: 7-26, 1993.
2. Okada, K., and Schroeder, F. Human prostatic carcinoma in cell culture: preliminary report on the development and characterization of an epithelial cell line. Urol. Res., 2: 111-121, 1974.
3. Stone, K. R., Mickey, D. D., Wunderli, H., Michey, G. H., and Paulson, D. F. Isolation of a human prostate carcinoma cell line (DU-145). Intl. J. Cancer, 21: 274-281, 1978.
4. Kaighn, M., Shakar Narayan, K., Ohnuki, Y., Lechner, J., and Jones, L. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Urology, 17: 16-23, 1979.
5. Horoszewicz, J. S, Leong, S. S., Chu, T. M., Wajsman, Z. L., Freedman, M., Papsidero, L., Kim, U., Chai, L. S., Kakaci, S., Arya, S. K., and Sandberg, A. A. The LnCaP cell line - a new model for studies on human prostatic carcinoma. Prog. Clin. Biol. Res., 37: 115-132, 1980.
6. Class, F., and Van Steenbrugge, G. J. Expression of HLA-like structures on a permanent human tumor line PC-93. Tissue Antigens, 21: 227-232, 1983.
7. Iizumi, T., Yazaki, T., Kanoh, S., Kondo, I., and Koiso, K. Establishment of a new prostatic carcinoma cell line (TSU-PR1). J. Urol., 137: 1304-1306, 1987.
8. Muraki, J., Addonizio, J., Choudhury, M., Fischer, J., Eshghi, M., Davidian, M, Sharppiro, L., Wilmot, P., Nagamatsu, G., and Chiao, J. Establishment of new human prostatic cancer cell (JCA-1). Invest. Urol., 36: 79-84, 1990.
9. Gingrich, J., Tucker, J., Walther, P., Day. J., Poulton, S., and Webb, K. Establishment and characterization of a new human prostatic carcinoma cell line (DuPro-1). J. Urol., 146: 915-919, 1991.
10. Narayan, P., and Dahiya, R. Establishment and characterization of a human primary prostatic adenocarcinoma line (ND-1). J. Urol., 148: 1600-1604, 1992.
11. Hoehn, W., Schoroeder, F. H., Riemann, J. F., Joebsis, A. C., and Hermanek, P. Human prostatic adenocarcinoma. some characteristics of a serially transplantable line in nude mice (PC 82). Prostate, 1: 95-104, 1980
12. Ito, Y. Z., Mashimo, S., Nakazato, Y., and Takikawa, H. Hormone dependency of a serially transplantable human prostatic cancer (HONDA) in nude mice. Cancer Res., 45. 5058-5063, 1985
13. Graham, S. D., Poulton, S. H., Linder, J., Woodard, B. H., Lyles, K. W., and Paulson, D. F. Establishment of a long-term adenocarcinoma of the prostate cell line in the nude mouse. Prostate. 7: 369-376, 1985.
14. Hoehn, W., Wagner, M., Riemann, J. F., Hermanek, P., Williams, E., Walther, R., and Schruffer, R. Prostatic adenocarcinoma PC-EW, a new human tumor line transplantable in nude mice. Prostate, 5: 445-452, 1984.
15. Van Steenbrugge, G., Groen, M., Bolt-de Vries, J., Romijn, J., and Schroeder, F. Human prostate cancer (PC-82) in nude mice: a model to study androgen regulated tumor srowth. Prog. Clin. Biol. Res., 185A: 23-50, 1985.
16. Caspo, Z., Brand, K., Walther, R., and Konstantinos, F. Comparative experimental study of the serum prostate specific antigen and prostate acid phosphatase in serially transplantable human prostatic carcinoma lines in nude mice. J. Urol., 140: 1032-1038, 1988.
17. Harper, M., Sibley, P., Rowlands, A., Buttifant, L., Beacock, C., and Griffiths, K. Hormonal modulation of the growth of a new transplantable prostatic cell line in athymic mice. Urol. Res., 14: 156A, 1986.
18. Gleave, M. E., Hsieh, J. T., Wu, H., Von Eschenbach, A C., and Chung, L. W. Evaluation of the pharmacokinetics of PSA using the LNCaP tumor model. J. Urol., 147: 694, 1992.
19. Gleason, D. F. Histologic grading in clinical staging of prostatic carcinoma. In: M. Tannenbaum (ed.), Urologic Pathology: The Prostate, pp. 171-179. Philadelphia: Lea & Febiger, 1977.
20. Beckett, M. L., Lipford, G. B., Haley, C. L., Schellhammer, P. E., Wright, G. L., Jr. Monoclonal antibody PD41 recognizes an antigen restricted to prostate adenocarcinomas. Cancer Res., 51: 1326-1333, 1991.
21. Starling, J. J., Sieg, S M., Beckett, M. L., Wirth, P. R., Wahab, Z., Schellhammer, P. F., Ladaga, L. E., Ploeskic, S., and Wright, G. L., Jr. Human prostate tissue antigens defined by murine monoclonal antibodies. Cancer Res., 46: 367-374, 1986.
22. Horoszewicz, J. S., Kawinski, E., and Murphy, G. P. Monoclonal antibodies to new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res., 7: 927-936, 1987.
23. Kaefer, M., Audia, J., Bruchovsky, N., Goode, R., Hsiao, K., Libovitch, I., Kruchinsky, J., Lee, C., Steidle, C., Sutowski, D., and Neubauer, B. Characterization of type I 5-alpha reductase activity in DU145 human prostatic adenocarcinoma cells. J. Steroid Biochem. Mol. Biol., in press, 1996.
24. Brothman, A. R., Peeh, D. M., Patel, A. M., and McNeal, J. E. Frequency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Res., 50: 3795-3803, 1990.
25. Brothman, A., Patel, A., Peehl, D., and Schellhammer, P. Analysis of prostatic tumor cultures using fluorescence in situ hybridization (FISH). Cancer Genet. Cytogenet., 62: 180-185, 1992.
26. Lim, D. J, Liu, X. L., Sutkowski, D. M., E. J. B., Lee, C., Kozlowski, J. M. Growth of an androgen-sensitive human prostate cancer cell line, LNCaP, in nude mice. Prostate, 22: 109-118, 1993.
27. Gleave, M. E., Hsieh, J. T., Wu, H. C., von Exchenbach, A. C., and Chung, L. W. K. Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors. Cancer Res., 52: 1598-1605, 1992.
28. Kyprianou, N., English, H., and Isaacs, J. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res., 50: 3748-3753, 1990.
29. Thigpen, A. E., Silver, R. I., Guileyardo, J. M., Casey, M. L., McConnell, J. D., and Russell, D. W. Tissue distribution and ontogeny of steroid 5 alpha-reductase isoenzyme expression. J. Clin. Invest., 92: 903-910, 1993.
30. Harris, G., Azzolina, B., Baginsky, W., Cimis, G., Rasmusson, G. H., Tolman, R. L., Raetz, C. R. H., and Ellsworth, K. Identification and selective inhibition of an isozyme of steroid 5 alpha-reductase in human scalp. Proc. Natl. Acad. Sci. USA, 89: 10787-10791, 1992.
31. Ellis, W. J., and Brawer, M. K. The role of tumor markers in the diagnosis and treatment of prostate cancer. In: H. Lepor and R. K. Lawson (eds.), Prostate Diseases, pp. 276-291. Philadelphia: W. B. Saunders Company, 1993.
32. Lilja, H. A kallikrem-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein J. Clin. Invest., 76: 1899-1903, 1985.
33. Wright, G. L., Jr., Beckett, M. L., Lipford, G. B., Haley, C. L., and Schellhammer, P. F. A novel prostate carcinoma-associated glycoprotein complex (PAC) recognized by monoclonal antibody Turp-27. Int. J. Cancer, 47: 717-725, 1991.
34. Israeli, R. S., Powell, C. T., Corr, J. G., Fair, W. R., and Heston, W. D. W. Expression of the prostate-specific membrane antigen. Cancer Res., 54: 1807-1811, 1994.